Maternal high-fat diet consumption modulates hepatic lipid metabolism and microRNA-122 (miR-122) and microRNA-370 (miR-370) expression in offspring

British Journal of Nutrition

Volumn 111, Issue 12, 2014, Pages 2112-2122

  Benatti, R O ^a   Melo, A M ^a   Borges, F O ^a   Ignacio Souza, L M ^b   Simino, L A P ^a   Milanski, M ^a   Velloso, L A ^a   Torsoni, M A ^a   Torsoni, A S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

Author keywords

High fat diet; Lipid metabolism; Maternal imprinting; MicroRNA; Obese mice

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CHOLESTEROL; FATTY ACID; FATTY ACID SYNTHASE; GLYCEROPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; I KAPPA B KINASE; MESSENGER RNA; MICRORNA; MICRORNA 122; MICRORNA 370; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ACYL COENZYME A DESATURASE 1; CARNITINE PALMITOYLTRANSFERASE I; TRIACYLGLYCEROL;

ACADVL GENE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CPT1 GENE; ENERGY EXPENDITURE; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FEMALE; GENE; GENE EXPRESSION; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; LACTATION; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; MALE; MATERNAL NUTRITION; MATERNAL OBESITY; MOUSE; NONHUMAN; PREGNANCY; PROGENY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ACYL COA DEHYDROGENASE VERY LONG CHAIN GENE; CARNITINE PALMITOYLTRANSFERASE 1 GENE; CHOLESTEROL BLOOD LEVEL; FAT MASS; LIVER METABOLISM;

MUS;

ADIPOSITY; ANIMALS; DIET, HIGH-FAT; FEMALE; FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCOSE INTOLERANCE; LACTATION; LIPID METABOLISM; LIVER; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MICE; MICRORNAS; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; RANDOM ALLOCATION; SPECIFIC PATHOGEN-FREE ORGANISMS; WEANING; WEIGHT GAIN;

EID: 84901305565     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514000579     Document Type: Article

References (59)

1. Danielzik S, Langnäse K, Mast M, et al. (2002) Impact of parental BMI on the manifestation of overweight 5-7 year old children. Eur J Nutr 41, 132-138.
2. Boney CM, Verma A, Tucker R, et al. (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115, e290-e296.
3. Catalano PM, Farrell K, Thomas A, et al. (2009) Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 90, 1303-1313.
4. Challier JC, Basu S, Bintein T, et al. (2008) Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 29, 274-281.
5. Elahi MM, Cagampang FR, Mukhtar D, et al. (2009) Longterm maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice. Br J Nutr 102, 514-519.
6. Ashino NG, Saito KN, Souza FD, et al. (2012) Maternal highfat feeding through pregnancy and lactation predisposes mouse offspring to molecular insulin resistance and fatty liver. J Nutr Biochem 23, 341-348.
7. Shankar K, Zhong Y, Kang P, et al. (2011) Maternal obesity promotes a proinflammatory signature in rat uterus and blastocyst. Endocrinology 152, 4158-4170.
8. Qureshi K & Abrams GA (2007) Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 13, 3540-3553.
9. Stanton MC, Chen SC, Jackson JV, et al. (2011) Inflammatory signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. J Inflamm (Lond) 8, 8
10. McCurdy CE, Bishop JM, Williams SM, et al. (2009) Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 119, 323-335.
11. Heerwagen MJ, Stewart MS, de la Houssaye BA, et al. (2013) Transgenic increase in n-3/n-6 fatty acid ratio reduces maternal obesity-associated inflammation and limits adverse developmental programming in mice. PLOS ONE 8, e67791.
12. Postic C & Girard J (2008) The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 34, 643-648.
13. Bouanane S, Merzouk H, Benkalfat NB, et al. (2010) Hepatic and very low-density lipoprotein fatty acids in obese offspring of overfed dams. Metabolism 59, 1701-1709.
14. Waterland RA (2005) Does nutrition during infancy and early childhood contribute to later obesity via metabolic imprinting of epigenetic gene regulatory mechanisms Nestle Nutr Workshop Ser Pediatr Program 56, 157-171, discussion 171-154.
15. Sullivan EL & Grove KL (2010) Metabolic imprinting in obesity. Forum Nutr 63, 186-194.
16. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
17. Li ZY, Xi Y, Zhu WN, et al. (2011) Positive regulation of hepatic miR-122 expression by HNF4a. J Hepatol 55, 602-611.
18. Yang YM, Seo SY, Kim TH, et al. (2012) Decrease of micro-RNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid. Hepatology 56, 2209-2220.
19. Iliopoulos D, Drosatos K, Hiyama Y, et al. (2010) MicroRNA-370 controls the expression of microRNA-122 and Cpt1a and affects lipid metabolism. J Lipid Res 51, 1513-1523.
20. Dell RB, Holleran S & Ramakrishnan R (2002) Sample size determination. ILAR J 43, 207-213.
21. Carr TP, Andresen CJ & Rudel LL (1993) Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 26, 39-42.
22. Newberry EP, Xie Y, Kennedy S, et al. (2003) Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene. J Biol Chem 278, 51664-51672.
23. Bonora E, Zavaroni I, Alpi O, et al. (1987) Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia 30, 719-723.
24. Stenseth NC, Viljugrein H, Saitoh T, et al. (2003) Seasonality, density dependence, and population cycles in Hokkaido voles. Proc Natl Acad Sci USA 100, 11478-11483.
25. Shoelson SE, Lee J & Yuan M (2003) Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity-and dietinduced insulin resistance. Int J Obes Relat Metab Disord 27, Suppl. 3, S49-S52.
26. Cnop M (2008) Fatty acids and glucolipotoxicity in the pathogenesis of type 2 diabetes. Biochem Soc Trans 36, 348-352.
27. Araú jo EP, Torsoni MA & Velloso LA (2010) Hypothalamic inflammation and obesity. Vitam Horm 82, 129-143.
28. Donath MY & Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11, 98-107.
29. Gregor MF & Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415-445.
30. Horng T & Hotamisligil GS (2011) Linking the inflammasome to obesity-related disease. Nat Med 17, 164-165.
31. Velloso LA & Schwartz MW (2011) Altered hypothalamic function in diet-induced obesity. Int J Obes (Lond) 35, 1455-1465.
32. Levin BE (2010) Interaction of perinatal and pre-pubertal factors with genetic predisposition in the development of neural pathways involved in the regulation of energy homeostasis. Brain Res 1350, 10-17.
33. Barbuio R, Milanski M, Bertolo MB, et al. (2007) Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. J Endocrinol 194, 539-550.
34. Cintra DE, Pauli JR, Araújo EP, et al. (2008) Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol 48, 628-637.
35. Wiedemann MS, Wueest S, Item F, et al. (2013) Adipose tissue inflammation contributes to short-term high-fat dietinduced hepatic insulin resistance. Am J Physiol Endocrinol Metab 305, E388-E395.
36. Turner N, Kowalski GM, Leslie SJ, et al. (2013) Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 56, 1638-1648.
37. Kraegen EW & Cooney GJ (2008) Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol 19, 235-241.
38. Samuel VT & Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852-871.
39. Farese RV Jr, Zechner R, Newgard CB, et al. (2012) The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab 15, 570-573.
40. Brown MS & Goldstein JL (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7, 95-96.
41. Jiang G, Li Z, Liu F, et al. (2005) Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1. J Clin Invest 115, 1030-1038.
42. Yokoyama S, Hosoi T & Ozawa K (2012) Stearoyl-CoA desaturase 1 (SCD1) is a key factor mediating diabetes in MyD88-deficient mice. Gene 497, 340-343.
43. Hodson L & Fielding BA (2013) Stearoyl-CoA desaturase: rogue or innocent bystander Prog Lipid Res 52, 15-42.
44. Takeuchi K & Reue K (2009) Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis. Am J Physiol Endocrinol Metab 296, E1195-E1209.
45. Hsu SH, Wang B, Kota J, et al. (2012) Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 122, 2871-2883.
46. Yu H, Bi Y, Ma W, et al. (2010) Long-term effects of high lipid and high energy diet on serum lipid, brain fatty acid composition, and memory and learning ability in mice. Int J Dev Neurosci 28, 271-276.
47. Silber GH, Hachey DL, Schanler RJ, et al. (1988) Manipulation of maternal diet to alter fatty acid composition of human milk intended for premature infants. Am J Clin Nutr 47, 810-814.
48. Priego T, Sánchez J, Garća AP, et al. (2013) Maternal dietary fat affects milk fatty acid profile and impacts on weight gain and thermogenic capacity of suckling rats. Lipids 48, 481-495.
49. Lewis GF, Carpentier A, Adeli K, et al. (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23, 201-229.
50. Ferré P & Foufelle F (2010) Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 12, Suppl. 2, 83-92.
51. Donnelly KL, Smith CI, Schwarzenberg SJ, et al. (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115, 1343-1351.
52. Esau C, Davis S, Murray SF, et al. (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3, 87-98.
53. Li S, Chen X, Zhang H, et al. (2009) Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J Lipid Res 50, 1756-1765.
54. Whittaker R, Loy PA, Sisman E, et al. (2010) Identification of microRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening. J Biomol Screen 15, 798-805.
55. Rayner KJ, Sheedy FJ, Esau CC, et al. (2011) Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest 121, 2921-2931.
56. Aranda JF, Madrigal-Matute J, Rotllan N, et al. (2013) MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. Free Radic Biol Med 64, 31-39.
57. Tsai WC, Hsu SD, Hsu CS, et al. (2012) MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 122, 2884-2897.
58. Krützfeldt J, Rajewsky N, Braich R, et al. (2005) Silencing of microRNAs in vivo with ?antagomirs?. Nature 438, 685-689.
59. Elmén J, LindowM, Schütz S, et al. (2008) LNA-mediated micro-RNA silencing in non-human primates. Nature 452, 896-899.